Brain tissue echogenicity—implications for substantia nigra studies in parkinsonian patients

被引:0
|
作者
Krzysztof Sadowski
Karol Szlachta
Małgorzata Serafin-Król
Jolanta Gałązka-Friedman
Andrzej Friedman
机构
[1] Medical University of Warsaw,Department of Neurology, Health Science Faculty
[2] Warsaw University of Technology,Faculty of Physics
[3] Medical University of Warsaw,Department of Diagnostic Imaging, IInd Medical Faculty
来源
关键词
Transcranial sonography; Iron; Ferritin; Parkinson’s disease; Substantia nigra hyperechogenicity;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the present study was to assess the origin of the substantia nigra hyperechogenicity in Parkinson disease patients. The cause of hyperechogenicity was tested on an animal model. Fresh porcine brains were injected consecutively with ferritin, apoferritin and water. Then, glioma samples were inserted into animal model. The echogenicity of the region of interest was assessed before and after experimental procedures. We observed the same echogenicity of porcine brain before and after injections of iron-loaded ferritin, apoferritin and water. Increased echogenicity of glioma samples compared to surrounding porcine brain tissue could be clearly seen. We postulate that the relative gliosis might be, at least partially, responsible for the increased echogenicity of the substantia nigra in Parkinson disease patients. Keeping in mind all limitations and inaccuracies of animal model used, it seems that hyperechogenicity of substantia nigra is caused rather by structural changes within the brain tissue than by increased iron concentration.
引用
收藏
页码:363 / 367
页数:4
相关论文
共 50 条
  • [21] Neurogenesis in Substantia Nigra of Parkinsonian Brains?
    Arias-Carrion, Oscar
    Yamada, Elizabeth
    Freundlieb, Nils
    Djufri, Miriam
    Maurer, Lukas
    Hermanns, Guido
    Ipach, Bastian
    Chiu, Wei-Hua
    Steiner, Corinna
    Oertel, Wolfgang H.
    Hoeglinger, Guenter U.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2009, (73): : 279 - 285
  • [22] On the question of apoptosis in the parkinsonian substantia nigra
    Siegfried Kösel
    Rupert Egensperger
    Ulrich von Eitzen
    Parviz Mehraein
    M. B. Graeber
    Acta Neuropathologica, 1997, 93 : 105 - 108
  • [23] IRON DISTRIBUTION IN THE SUBSTANTIA-NIGRA OF PARKINSONIAN BRAIN - PIXE ANALYSIS
    AOTSUKA, A
    SHINOTOH, H
    KITAO, K
    ARAI, K
    HIRAYAMA, K
    FUKUDA, H
    ANNALS OF NEUROLOGY, 1992, 32 (02) : 248 - 248
  • [24] Iron in the Parkinsonian substantia nigra - Reply
    Friedman, A
    GalazkaFriedman, J
    Bauminger, ER
    Hechel, D
    Nowik, I
    Barcikowska, M
    MOVEMENT DISORDERS, 1997, 12 (02) : 259 - 260
  • [25] Potential sources of increased iron in the substantia nigra of parkinsonian patients
    Gerlach, M.
    Double, K. L.
    Youdim, M. B. H.
    Riederer, P.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2006, (70): : 133 - 142
  • [26] Substantia nigra echogenicity and olfactory function as predictors for mild Parkinsonian signs: A prospective population-based study
    Mahlknecht, P.
    Kiechl, S.
    Willeit, J.
    Stockner, H.
    Gasperi, A.
    Poewe, W.
    Seppi, K.
    MOVEMENT DISORDERS, 2014, 29 : S546 - S546
  • [27] Echogenicity of the substantia nigra region in Parkinson's disease
    Bar-Seng-Shu, Edson
    Almeida, Kelson James
    de Andrade, Daniel Ciampi
    Fonoff, Erich Talamoni
    Teixeira, Manoel Jacobsen
    Barbosa, Egberto Reis
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2012, 70 (02) : 153 - 154
  • [28] The history of the research of iron in parkinsonian substantia nigra
    Andrzej Friedman
    Jolanta Galazka-Friedman
    Journal of Neural Transmission, 2012, 119 : 1507 - 1510
  • [29] Imaging Parkinsonian Pathology in Substantia Nigra with MRI
    Huddleston D.E.
    Langley J.
    Dusek P.
    He N.
    Faraco C.C.
    Crosson B.
    Factor S.
    Hu X.P.
    Current Radiology Reports, 6 (4)
  • [30] Sonographic evaluation of substantia nigra in parkinsonian syndromes
    Bartova, P.
    David, S.
    Fadrna, T.
    Ressner, F.
    Kanovsk, P.
    Herzig, R.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S159 - S159